FI954190A - Heterosykli-N-oksidisubstituoituja bentsoyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä välituotteita niiden valmistamiseksi - Google Patents

Heterosykli-N-oksidisubstituoituja bentsoyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä välituotteita niiden valmistamiseksi Download PDF

Info

Publication number
FI954190A
FI954190A FI954190A FI954190A FI954190A FI 954190 A FI954190 A FI 954190A FI 954190 A FI954190 A FI 954190A FI 954190 A FI954190 A FI 954190A FI 954190 A FI954190 A FI 954190A
Authority
FI
Finland
Prior art keywords
alkyl
opt
preparation
ome
oxide
Prior art date
Application number
FI954190A
Other languages
English (en)
Swedish (sv)
Other versions
FI954190A0 (fi
Inventor
Heinz-Werner Kleemann
Hans-Jochen Lang
Jan-Robert Schwark
Andreas Weichert
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI954190A0 publication Critical patent/FI954190A0/fi
Publication of FI954190A publication Critical patent/FI954190A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
FI954190A 1994-09-09 1995-09-07 Heterosykli-N-oksidisubstituoituja bentsoyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä välituotteita niiden valmistamiseksi FI954190A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4432106A DE4432106A1 (de) 1994-09-09 1994-09-09 Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FI954190A0 FI954190A0 (fi) 1995-09-07
FI954190A true FI954190A (fi) 1996-03-10

Family

ID=6527788

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954190A FI954190A (fi) 1994-09-09 1995-09-07 Heterosykli-N-oksidisubstituoituja bentsoyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä välituotteita niiden valmistamiseksi

Country Status (22)

Country Link
US (1) US5641792A (fi)
EP (1) EP0700904B1 (fi)
JP (1) JP4113262B2 (fi)
KR (1) KR960010619A (fi)
CN (1) CN1119643A (fi)
AT (1) ATE210121T1 (fi)
AU (1) AU695342B2 (fi)
CA (1) CA2157855C (fi)
CZ (1) CZ291188B6 (fi)
DE (2) DE4432106A1 (fi)
DK (1) DK0700904T3 (fi)
ES (1) ES2168324T3 (fi)
FI (1) FI954190A (fi)
HU (1) HU219976B (fi)
IL (1) IL115196A (fi)
NO (1) NO305202B1 (fi)
NZ (1) NZ272946A (fi)
PL (1) PL310346A1 (fi)
PT (1) PT700904E (fi)
RU (1) RU2160727C2 (fi)
SI (1) SI9500280B (fi)
ZA (1) ZA957548B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19737224A1 (de) 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP1814838A4 (en) * 2004-11-16 2010-03-17 Merck Sharp & Dohme PRODRUGS FROM (2R) -2-PROPYLOCTANIC ACIDS FOR THE TREATMENT OF APOPLEXIA

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE271903C (fi) *
US3780027A (en) 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE2258276C3 (de) * 1972-11-28 1981-08-13 Bayer Ag, 5090 Leverkusen Triazolyl-stilbene, sowie deren Herstellung und Verwendung als optische Aufheller
US3931181A (en) * 1973-07-27 1976-01-06 Hoffmann-La Roche Inc. 2,4-Diamino-5-benzylpyrimidines
JPS59510B2 (ja) * 1973-11-22 1984-01-07 塩野義製薬株式会社 ピリジンユウドウタイ ノ セイゾウホウ
US4373024A (en) 1980-12-02 1983-02-08 Phillips Petroleum Company Apparatus useful for foam breaking
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
DD271903A1 (de) * 1988-05-17 1989-09-20 Univ Halle Wittenberg Verfahren zur herstellung stabiler, 2-unsubstituierter imidazol-3-oxide
US4959377A (en) * 1989-06-29 1990-09-25 Hoechst-Roussel Pharmaceuticals Inc. Phenoxypyridinamine compounds which are use as a dermatological composition
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
DE59302959D1 (de) * 1992-02-15 1996-07-25 Hoechst Ag 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen
TW250479B (fi) * 1992-12-15 1995-07-01 Hoechst Ag

Also Published As

Publication number Publication date
DE4432106A1 (de) 1996-03-14
PL310346A1 (en) 1996-03-18
CA2157855A1 (en) 1996-03-10
DK0700904T3 (da) 2002-03-18
CN1119643A (zh) 1996-04-03
KR960010619A (ko) 1996-04-20
JPH0892215A (ja) 1996-04-09
PT700904E (pt) 2002-05-31
ATE210121T1 (de) 2001-12-15
CZ291188B6 (cs) 2003-01-15
JP4113262B2 (ja) 2008-07-09
AU3050495A (en) 1996-03-21
FI954190A0 (fi) 1995-09-07
CA2157855C (en) 2009-04-21
IL115196A (en) 2003-01-12
CZ231595A3 (en) 1996-04-17
DE59509899D1 (de) 2002-01-17
SI9500280B (en) 2001-12-31
US5641792A (en) 1997-06-24
EP0700904B1 (de) 2001-12-05
SI9500280A (en) 1996-04-30
HUT72630A (en) 1996-05-28
HU219976B (hu) 2001-10-28
NO953555L (no) 1996-03-11
EP0700904A1 (de) 1996-03-13
NO953555D0 (no) 1995-09-08
HU9502634D0 (en) 1995-11-28
ZA957548B (en) 1996-04-17
ES2168324T3 (es) 2002-06-16
RU2160727C2 (ru) 2000-12-20
AU695342B2 (en) 1998-08-13
IL115196A0 (en) 1995-12-31
NZ272946A (en) 1996-12-20
NO305202B1 (no) 1999-04-19

Similar Documents

Publication Publication Date Title
FI954190A (fi) Heterosykli-N-oksidisubstituoituja bentsoyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä välituotteita niiden valmistamiseksi
HRP960496B1 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic, and medicament containing them
EP0686627A3 (de) Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
FI954192A0 (fi) Aminohapolla substituoidut bentsoyyliguaniidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
NO952450D0 (no) Fenylsubstituerte alkenylkarboksylsyreguanidider som bærer perfluoralkylgrupper, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt mediakament inneholdende forbindelsen
GB1257225A (fi)
IL41426A (en) Process for the production of history 3 - amino - benzo - 1, 2, 4, - triazine di N - oxides and pharmaceutical preparations containing such history
ATE96778T1 (de) Bis-guanidine und diese enthaltende fungizide.
GR3033049T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them
HU913520D0 (en) Process for the production of 7-acyl-3(substituted carbamoiloxy)-cefem-derivatives and of the medical preparations containing them
GB1132583A (en) Pharmaceutical compositions containing cephalosporins
NO306293B1 (no) Benzoylguanidiner, deres anvendelse for fremstilling av legemiddel eller diagnostikum sÕvel som medikamenter inneholdende dem
GB1391577A (en) Pseudosynovial plastic body fluids and method of preparing same
JPH06700B2 (ja) 安定な水性液剤
GB1274553A (en) Hydroxyalkylene-substituted benzoxazines and benzothiazines
GB993453A (en) New derivatives of heparin and processes for their preparation
TH1527EX (th) ซับสทิทิวเทด พิริมิดีน